R. Kohling et al., EXTRACELLULAR POTASSIUM ELEVATIONS IN THE HIPPOCAMPUS OF RATS WITH LONG-TERM PILOCARPINE SEIZURES, Neuroscience letters, 201(1), 1995, pp. 87-91
Pilocarpine injection into rodents leads to the development of chronic
limbic seizures that follow an initial status epilepticus and a seizu
re-free interval. It has been proposed that a decreased efficacy of th
e mechanisms that buffer the extracellular concentration of K+ ([K+](0
)) leads to an increase in seizure susceptibility. Therefore, we analy
zed the changes in [K+](0) associated with the synchronous activity in
duced by 4-aminopyridine (4AP) in hippocampal slices obtained from con
trol and pilocarpine-treated rats. At all recording sites (i.e. stratu
m radiatum of the CA1 and CA3 subfields, and hilus of the dentate gyms
), the amplitude of GABA-mediated synchronous field potentials induced
by 4AP, as well as the associated [K+](0) increases, were significant
ly reduced in slices obtained from the pilocarpine-treated rats. In th
e control group, the field-potential amplitudes reached 1 mV (i.e. 1.7
+/- 0.3 mV in CA1, 0.93 +/- 0.2 mV in CA3, and 1.03 +/- 0.12 mV in th
e hilus; mean +/- SEM), while the accompanying rises in [K+](0), excee
ded 4 mM (i.e. 4.17 +/- 0.15 mM in CA1, 4.04 +/- 0.12 mM in CA3, 4.04
+/- 0.11 mM in the hilus) from a baseline of 3.25 mM. The correspondin
g values in slices from the pilocarpine-treated group were rarely grea
ter than 0.4 mV (i.e. 0.3 +/- 0.09 mV in CA1, 0.27 +/- 0.03 mV in CA3
and 0.38 +/- 0.06 mV in the hilus), and larger than 3.6 mM (i.e. 3.63
+/- 0.04 mM in CA1, 3.64 +/- 0.03 mM in CA3 and 3.60 +/- 0.04 mM in th
e hilus) from a similar baseline value. With pilocarpine, the rate of
occurrence of the GABA-mediated potential significantly decreased from
0.035 to 0.016 s(-1). Since the rises in [K+](0) decreased rather tha
n increased and their overall duration was unchanged (possibly reflect
ing cell loss), we conclude that a modification of [K+](0) buffering c
apacity is unlikely to account for the appearance of in vivo seizures
in the pilocarpine model of epilepsy.